Evidence map›Paper›PMID 29744721›Full record

Trial reportClinical oral investigations2019

The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.

Burcu Nihan Çelik, Merve Safa Mutluay, Volkan Arıkan, Şaziye Sarı

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05812053 (Comparative Evaluation of Eggshell Powder Versus Biodentine in Primary Teeth Pulpotomy), which is not on this map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05812053 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparative Evaluation of Eggshell Powder Versus Biodentine in Primary Teeth Pulpotomy: Clinical And Radiographic Study

TypeinterventionalSponsorTanta UniversityRan2023 to 2026Enrolled30ConditionsPulpitis Reversible, Pulp Exposure, DentalArmspulpotomy, cone beam computed tomography (CBCT) assessment
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Contemporary management of deep caries in primary teeth: a systematic review and meta-analysis.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2022
    Pooled it
  3. Clinical effectiveness of restorative materials for the restoration of carious lesions in pulp treated primary teeth: a systematic review.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2022
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. A retrospective study on iRoot BP Plus full pulpotomy for primary molars with partial irreversible pulpitis.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Burcu Nihan ÇelikDepartment of Pedodontics, Faculty of Dentistry, Ankara University, Ankara, Turkey. bncelik@ankara.edu.tr.
Merve Safa MutluayVocational School of Health Services, Kırıkkale University, Kırıkkale, Turkey.
Volkan ArıkanDepartment of Pedodontics, Faculty of Dentistry, Kırıkkale University, Kırıkkale, Turkey.
Şaziye SarıDepartment of Pedodontics, Faculty of Dentistry, Ankara University, Ankara, Turkey.
Ankara University · TRKırıkkale University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study examined the effects of MTA and Biodentine on the clinical and radiographic success rates of pulpotomies performed on primary teeth with carious pulp exposures. MATERIALS AND

methodsThis study was conducted with 44 mandibular primary molars requiring vital pulpotomy. Carious dentin surrounding the exposure site was used as the inclusion criteria for all teeth, which were randomly divided into two groups according to pulpotomy material [MTA group (n = 24), Biodentine group (n = 20)]. Treatment was followed up clinically and radiologically for 24 months. Pulp canal obliteration was not regarded as a failure.

resultsClinical and radiographic success rates at the end of 24 months were 100% for the MTA group and 89.4% for the Biodentine group. Success rates did not vary significantly between the groups (p = 0.646). Pulp canal obliteration was observed in two teeth (8.3%) in the MTA group at 6 months, but the teeth were found to be stabilized by 24 months.

conclusionThe long-term clinical and radiographic success rates obtained in this study indicate that both MTA and Biodentine are appropriate options for pulpotomy treatment of primary teeth with carious exposure in patients whose teeth should be retained for long periods of time. CLINICAL RELEVANCE: The etiology of exposure determines pulpal response, making it crucial to distinguish between mechanical and carious exposures. The carious exposure is presumed to be accompanied by severe inflammation, which makes the prognosis of treatment unpredictable. Biomaterials can be used especially in cases with carious pulp exposures.

Indexed as

Aluminum CompoundsCalcium CompoundsChildChild, PreschoolDental CariesDrug CombinationsFemaleHumansMaleMolarOxidesPulp Capping and Pulpectomy AgentsPulpotomySilicatesTooth, DeciduousTreatment OutcomeAluminum CompoundsCalcium CompoundsDrug Combinationsmineral trioxide aggregateOxidesPulp Capping and Pulpectomy AgentsSilicatestricalcium silicateBiodentineCarious exposureMineral trioxide aggregatePrimary teethVital pulpotomy

Identifiers

PMID29744721
OpenAlexW2801809025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.